• Integrated Kidney Care of Central California, LLC

    KCE Located In: Central California

  • Integrated Kidney Care of Central California, LLC

    KCE Located In: Central California

Clinical and Administrative Leadership

Kerri Green
Primary Contact & Administrative Leader
Director, DaVita IKC

Jasjit Singh
KCE Clinical Leader
The Nephrology Group

Governing Body Designees

Kelley Montgomery
The Nephrology Group

Hemant Dhingra
The Nephrology Group

Kavya Relan
DaVita IKC

Bryan McClintock
DaVita IKC

Dana Lucka
Consumer Advocate


Participant Groups and Providers

THE NEPHROLOGY GROUP INC

ADELA AYALA

AMARINDER GARCHA

ANURADHA SURI

ATULKUMAR ROY

CAROL ROSS MCCORMICK

DANIEL IKEMIYASHIRO

DENISE TRAN

DENNIS REDUBLA

DOMINIQUE DORSAINVIL

GREGORY MARTINEZ

HARMEET GURM

HARPREET DHINDSA

HASHIM KAZMI

HEMANT DHINGRA

HOMER PUNSALAN

JASJIT SINGH

JUDY XIONG

JOSEPH DUFLOT

LANIGAIL PANGILINAN

MEI-TSUEY HWANG

MELISA ARREGUIN

NEYSHA SANCHEZ RIVERA

NISHKARSH SAXENA

PANKAJ RAM

PREETI PAL

SHANG KNESEK

SLAMAT ALI

SREEDHAR ADAPA

STEPHANIE DAVILA-GOMEZ

STEVE SU

STEVEN LEVY

SUDHIR JOSHI

SUKHVIR ATWAL

WEI-TZUOH CHEN

YANGMING CAO

Preferred Groups and Providers

VILLAGEHEALTH DM LLC

Quality Measures

  • The Depression Response measure is a patient-reported outcome measure that assesses the percentage of adult patients (18 years of age or older) who score >9 on the Patient Health Questionnaire (PHQ-9), have a diagnosis of major depression or dysthymia and who demonstrate a response to treatment at approximately 12 months.
  • The Patient Activation Measure (PAM) licensed through Insignia Health (a Phreesia company), assesses the attitudes, motivators, and behaviors that allow a patient to manage his or her healthcare issues. Patient activation is essential to achieving improved health outcomes and cost control.
  • Optimal ESRD Starts quantifies the ability of healthcare providers to prepare patients for ESRD by educating them and their families about the need for dialysis or kidney transplant, helping them to make appropriate and informed choices about their treatment modality, and supporting them in successfully transitioning to dialysis or kidney transplantation as kidney function declines.

Shared Savings and Losses

  • Total amount of Shared Savings or Shared Losses per Performance Year
  • Proportion of Shared Savings invested in the program and other resources necessary to improve outcomes and reduce Medicare costs for Beneficiaries
  • Proportion of Shared Savings to KCE Participants and Preferred Providers for each Performance Year

For a full list of facilities and joint ventures, please click here.

For more information on CKCC, email CMMImodels@davita.com or click here.